Wei et al. [32] demonstrated that miR-296 regulates the HMGA1 expression in patients with prostate cancer, noting that high levels of HMGA1 were associated with low expression levels of miR-296 and strongly associated with more advanced disease stage. This evidence concerns the gene HMGA1 and prostate carcinoma.